Tissue Diagnostics Market Size, Share, Expected Growth And Industry...

Tissue Diagnostics Market Size, Share, Expected Growth And Industry Analysis Report to 2032

Posted 2024-02-15 16:54:24

According to a new report published by K D Market Insights, titled, “Tissue Diagnostics Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global tissue diagnostics market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The increasing prevalence of cancer and other chronic diseases, advancements in diagnostic technologies, and a rising geriatric population which are the major factors augmenting the growth of the global tissue diagnostics market. Tissue diagnostics play a crucial role in disease diagnosis, prognosis, and treatment decision-making, driving the demand for related products and services.

The increasing prevalence of cancer and chronic diseases drives the demand for accurate and reliable diagnostic techniques. Tissue diagnostics play a crucial role in cancer diagnosis, staging, and personalized treatment selection which is further expected to create ample growth opportunities for the global tissue diagnostics market during the forecast period i.e., 2023-2032. Moreover, technological advancements in tissue diagnostics, such as automation, digital imaging, and molecular testing, have improved the accuracy and efficiency of diagnostics, which is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global tissue diagnostics market in 2022. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the high prevalence of cancer, well-established healthcare infrastructure, and extensive research and development activities.

According to technology, the immunohistochemistry (IHC) segment accounted for the largest market share in the tissue diagnostics market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global tissue diagnostics market is segmented into product, technology, disease, end user and region. Based on product, the market is bifurcated into consumables (antibodies, kits, reagents, probes), instruments (slide staining system, scanners, tissue processing system). Based on technology, it is classified into immunohistochemistry, in situ hybridization, digital pathology and workflow management, special staining. Based on disease, it is classified into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, other diseases. Based on end user, it is classified into hospitals, pharmaceutical companies, research laboratories, contract research organizations, other end users.

The global tissue diagnostics market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Light Therapy Market

On the basis of technology, the immunohistochemistry (IHC) segment accounted for the largest market share in the tissue diagnostics market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
On the basis of region, North America accounted for the largest share in the global tissue diagnostics market in 2022. The region is further projected to continue dominating in the market during the forecast period.
On the basis of region, Europe is estimated to account for the second largest share in the market during the forecast period.

Some of the major tissue diagnostics companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Inc, Abbott, Agilent Technologies Inc., Merck KGAA, SAKURA FINETEK JAPAN CO., LTD, Abcam Plc., Becton, Dickinson and Company (BD), Bio SB, Biogenix, Cell Signaling Technology, Inc, Histo-Line Laboratories, SLEE Medical GMBH, and Hologic Inc.

Related Reports :-

https://www.kdmarketinsights.com/reports/refurbished-medical-equipment-market/5209